Takeda Pharmaceutical Co. Ltd. · TSE:4502
Takeda Pharmaceutical — Investor Presentation (May 2024)
14 slides from Takeda Pharmaceutical's investor presentation, May 2024
Slide 1: India Corporate Overview
INDIA CORPORATE OVERVIEW Better Health, Brighter Future Last Updated May 2024
Slide 2: Supporting Patients for 242 Years
“At Takeda, patients always come first. We also believe that a focus on trust, reputation, and business, in that order, sets us apart” Christophe Weber President & CEO SUPPORTING PATIENTS 2 FOR 242 YEARS
Slide 3: Who We Are
Who We Are Creating better health for people and a brighter future for the world is Takeda’s purpose. The science and technology we advance are constantly evolving, but through our enduring values, our ambition remains steadfast. We strive to deliver truly transformative treatments, contributing sig
Slide 4: Our Corporate Philosophy
Our Corporate Philosophy Purpose Better health for people, brighter future for the world. Discover and deliver life-transforming treatments, guided by Vision our commitment to patients, our people and the planet. We are guided by our values of Takeda-ism which incorporate Values: Integrity, Fairness
Slide 5: A Global Biopharmaceutical Company
A Global Biopharmaceutical Company FOUNDED IN 1781 OSAKA, JAPAN PRESENCE IN 25+ ~50,000 ~80 MANUFACTURING COUNTRIES & REGIONS SITES EMPLOYEES GLOBAL HUB GLOBAL HEADQUARTERS CAMBRIDGE, MA, USA TOKYO, JAPAN 5 ALL NUMBERS AS OF JUNE 2023
Slide 6: Research and Development
Research and Development SMALL MOLECULES Approx. • BIOLOGICS 75% 30 • CELL THERAPIES NEW MOLECULAR ENTITY CLINICAL STAGE ASSETS • OTHER MODALITIES • PEPTIDES & OLIGONUCLEOTIDES 200 + $4.8 Bn * Robust Clinical Pipelines Diversified Modalities Active Partnerships R&D Investment of Novel Mechanisms in
Slide 7: Takeda in India
Takeda in India Mission Delivering sustainable access by providing innovative healthcare solutions to a diverse ecosystem TAKEDA BIOPHARMACEUTICALS NYCOMED GROUP’S TO INDIA PRIVATE LIMITED ACQUISITION Global level acquisition of Baxalta by Followed by global acquisitions, the Takeda’s global footpri
Slide 8: Takeda India Leadership Team
Takeda India Leadership Team ANNAPURNA DAS General Manager SHASHANK SHANBHAG NEHA JAIN ANKIT PANTHARI ANJANA NARAIN GOPAL AGRAWAL RUCHI SOGARWAL DR. SANDEEP ARORA Commercial Immunology & GI | Rare Vaccines | Market Access Corporate Medical Affairs & Business Operations Diseases Oncology (Interim) &
Slide 9: Our Passion for People Transforms Our Work Into Meaningful Action
Our Passion for People Transforms Our Work Into Meaningful Action We believe we can create an exceptional people experience for everyone at Takeda by focusing on these four areas: Talent Well-being Develop and attract top talent to Focus on empowering life-work deliver our vision with a highly align
Slide 10: We Aim to Discover and Deliver Life-transforming Treatments
We Aim to Discover and Deliver Life-transforming Treatments GASTROINTESTINAL & PLASMA-DERIVED THERAPIES INFLAMMATION • Immunodeficiencies • Neuroimmunology • Inflammatory Bowel disease (IBD) • Hematology • Celiac disease • Pulmonology • Dermatological & Rheumatic diseases • Specialty & critical care
Slide 11: Leading Beyond Medicines
Leading Beyond Medicines We strive to transform healthcare through partnerships & collaborations ensuring sustainability of patient care SMALL MOLECULES 75% PARTNERSHIPS AND COLLABORATIONS • BIOLOGICS Access First Strengthen Foster Healthcare patient-centric Approach healthcare to ensure System ecos
Slide 12: Strategic Initiatives & Partnerships
Strategic Initiatives & Partnerships BIRAC BIOLOGICAL E. LIMITED INNOVATION CAPABILITY CENTRE MoU with BIRAC to foster Manufacturing partnership Set up Innovation healthcare innovation with Biological E. Limited to Capability Centre in and technological accelerate Takeda’s efforts to Bangalore to en
Slide 13: Our Commitment to Society
Our Commitment to Society CSR Strategic Priorities FY23 -25 Impact (FY23) Health Systems Strengthening Community Care Environmental Sustainability Enhance healthcare and Building community Promote environmental sanitation service delivery resilience through community betterment through systems and c
Slide 14: Visit us online
Visit us online at www.takeda.com/en-in Published: 31st May, 2024 India Corporate Affairs www.takeda.com Disclaimer: The information contained herein is available to the public for information purposes only; it should not be used for diagnosing or treating a health problem or disease. The informatio
Takeda Pharmaceutical Company — Investor Presentation (May 2024) on 6ix